- Home
- MOGU vs SABS Comparison
MOGU vs SABS Comparison
Compare MOGU & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- SABS
- Stock Information
- Founded
- MOGU 2011
- SABS 2014
- Country
- MOGU China
- SABS United States
- Employees
- MOGU N/A
- SABS N/A
- Industry
- MOGU Business Services
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- SABS Health Care
- Exchange
- MOGU Nasdaq
- SABS Nasdaq
- Market Cap
- MOGU 17.8M
- SABS 15.8M
- IPO Year
- MOGU 2018
- SABS N/A
- Fundamental
- Price
- MOGU $2.08
- SABS $1.74
- Analyst Decision
- MOGU
- SABS Strong Buy
- Analyst Count
- MOGU 0
- SABS 5
- Target Price
- MOGU N/A
- SABS $11.80
- AVG Volume (30 Days)
- MOGU 4.0K
- SABS 17.6K
- Earning Date
- MOGU 07-08-2025
- SABS 08-07-2025
- Dividend Yield
- MOGU N/A
- SABS N/A
- EPS Growth
- MOGU N/A
- SABS N/A
- EPS
- MOGU N/A
- SABS N/A
- Revenue
- MOGU $19,801,126.00
- SABS $377,835.00
- Revenue This Year
- MOGU N/A
- SABS N/A
- Revenue Next Year
- MOGU N/A
- SABS N/A
- P/E Ratio
- MOGU N/A
- SABS N/A
- Revenue Growth
- MOGU N/A
- SABS N/A
- 52 Week Low
- MOGU $1.81
- SABS $1.00
- 52 Week High
- MOGU $3.14
- SABS $5.01
- Technical
- Relative Strength Index (RSI)
- MOGU 52.62
- SABS 49.33
- Support Level
- MOGU $2.05
- SABS $1.60
- Resistance Level
- MOGU $2.17
- SABS $1.87
- Average True Range (ATR)
- MOGU 0.05
- SABS 0.11
- MACD
- MOGU 0.01
- SABS -0.01
- Stochastic Oscillator
- MOGU 92.86
- SABS 62.07
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.